Белгия - нидерландски - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ceres pharma sa-nv - ethinylestradiol 0,03 mg; levonorgestrel 0,15 mg - filmomhulde tablet - 30 µg - 150 µg - ethinylestradiol 30 µg; levonorgestrel 150 µg - levonorgestrel and ethinylestradiol

Белгия - нидерландски - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ceres pharma sa-nv - levonorgestrel 0,1 mg; ethinylestradiol 0,02 mg - filmomhulde tablet - 20 µg - 100 µg - levonorgestrel 100 µg; ethinylestradiol 20 µg - levonorgestrel and ethinylestradiol

Европейски съюз - нидерландски - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - cannabidiol - lennox gastaut syndrome; epilepsies, myoclonic - van anti-epileptica, - epidyolex is geïndiceerd voor gebruik als adjuvante therapie van aanvallen in verband met het lennox-gastaut syndroom (lgs) of dravet syndroom (ds), in combinatie met clobazam, voor de patiënten van 2 jaar en ouder.

Европейски съюз - нидерландски - EMA (European Medicines Agency)

dechra regulatory b.v. - mirtazapine - psychoanaleptics, antidepressants in combination with psycholeptics - cats - voor het lichaamsgewicht in katten last hebt van een slechte eetlust en gewichtsverlies als gevolg van chronische medische aandoeningen.

Европейски съюз - нидерландски - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - astma - geneesmiddelen voor obstructieve aandoeningen van de luchtwegen, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Европейски съюз - нидерландски - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol acetate, mometasone furoate - astma - geneesmiddelen voor obstructieve aandoeningen van de luchtwegen, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Европейски съюз - нидерландски - EMA (European Medicines Agency)

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - longaandoening, chronisch obstructief - geneesmiddelen voor obstructieve aandoeningen van de luchtwegen, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Европейски съюз - нидерландски - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - eprinomectin, esafoxolaner, praziquantel - eprinomectin, combinations, , avermectins, antiparasitic products, insecticides and repellents - cats - for cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. het diergeneesmiddel is uitsluitend geïndiceerd bij alle drie de groepen zijn gericht op hetzelfde moment.

Европейски съюз - нидерландски - EMA (European Medicines Agency)

teva b.v. - salmeterol xinafoate, fluticasone propionate - astma - geneesmiddelen voor obstructieve aandoeningen van de luchtwegen, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Европейски съюз - нидерландски - EMA (European Medicines Agency)

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - geneesmiddelen voor obstructieve aandoeningen van de luchtwegen, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.